| ¿µ¹® | IDDM(Insulin-Dependent Diabetes Mellitus) | ÇÑ±Û | Àν¶¸°ÀÇÁ¸´ç´¢º´ |
|---|---|---|---|
| ¼³¸í | IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁÖ·Î ¿øÀÎÀÌ ÀÌÀÚ¿¡ ÀÖ´Â Àν¶¸°À» ºÐºñÇÏ´Â ¼¼Æ÷ÀÇ ÆÄ±«À̸ç ÀÌ·Î ÀÎÇØ¼ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²ÀÌ´Â Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇÏ´Â ¾à¹°ÀÌ ÀÌ IDDM¿¡¼´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀÎ Àν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù. |
||
| ¿µ¹® | diabete mellitus | ÇÑ±Û | ´ç´¢º´ |
|---|---|---|---|
| ¼³¸í | Àν¶¸°À̶õ ÀÌÀÚ¿¡¼ ºÐºñµÇ´Â È£¸£¸óÀ¸·Î ÁÖ·Î ¼·ÃëµÈ ¿µ¾ç¼ÒÀÇ ÀúÀåÀ» ÃËÁø½ÃŰ´Â ¿ªÇÒÀ» Çϴ ȣ¸£¸óÀÌ´Ù. ƯÈ÷ Èí¼öµÇ¾î Ç÷¾×¿¡ Á¸ÀçÇÏ´Â ´çÀ» ¿Â¸öÀÇ ¼¼Æ÷¼ÓÀ¸·Î À̵¿½ÃÄÑ ÀúÀåÇÏ°Ô Çϸç, ¿¡³ÊÁö¿øÀ¸·Î »ç¿ëÇÏ°Ô ÇÏ´Â ¿ªÇÒµµ ÇÑ´Ù. Áï Àν¶¸°Àº Ç÷¾×¼ÓÀÇ ´çÀ» ¼¼Æ÷¼ÓÀ¸·Î À̵¿½ÃÄÑ ±×°ÍÀ» ¿¡³ÊÁö¿øÀ¸·Î »ç¿ëÇÏ°Ô ÇÏ°í ´Ù¸¥ Áö¹æ, ´Ü¹éÁú µîÀÇ ¿µ¾ç¼Òµµ ¿ª½Ã ¼¼Æ÷¼Ó¿¡ ÀúÀå½ÃŰ´Â ¿ªÇÒÀ» ÇÑ´Ù. ¸¸¾à Àν¶¸°ÀÇ ºÐºñ°¡ ÃéÀå¿¡¼ Àû¾îÁú °æ¿ì¿¡´Â ¼¼Æ÷µéÀº ¼Òȵǰí Èí¼öµÇ¾î¼ Ç÷¾× Áß¿¡ Á¸ÀçÇÏ´Â ´çºÐÀ» Èí¼öÇÏÁö ¸øÇϰí, À̰͵éÀ» ¿¡³ÊÁö¿øÀ¸·Î ÀÌ¿ëÇÏÁö ¸øÇÏ°Ô µÈ´Ù. ±×·¯¹Ç·Î Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ´Â ³ô¾ÆÁö°Ô µÈ´Ù. ¶ÇÇÑ ´Ü¹éÁúÀ̳ª Áö¹æÀÌ ¼¼Æ÷¼Ó¿¡ ÀúÀåÀÌ µÇ´Â °Íµµ ¾ïÁ¦°¡ µÈ´Ù. ´ç´¢º´À̶õ ÀÌÀÚ¿¡¼ÀÇ Àν¶¸° ºÐºñÀÇ Àý´ëÀû, ¶Ç´Â »ó´ëÀû ºÎÁ·À̳ª, ¼¼Æ÷µé¿¡ ´ëÇÑ Àν¶¸°ÀÇ »ý¹°ÇÐÀû È¿°ú °¨¼Ò·Î ÀÎÇÏ¿© ¹ß»ýµÇ´Â °íÇ÷´ç(Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ°¡ ³ô¾ÆÁö´Â °Í) »óÅ ¹× ÀÌ¿¡ ¼ö¹ÝµÇ´Â ´ë»çÀå¾Ö°¡ Àå±â°£ Áö¼ÓµÇ´Â »óÅ·ΠƯ¡Áö¿öÁö´Â º´ÀÌ´Ù. ¢Â´ç´¢º´ÀÇ Áõ»ó ´ç´¢º´ÀÇ °¡Àå ÀüÇüÀûÀÎ Áõ»óÀº ´Ù´¢, °¥Áõ, üÁß°¨¼Ò, ¼è¾à°¨ µîÀÇ Áõ»óÀÌ´Ù. ÀÌ·¯ÇÑ Áõ»ó À̿ܿ¡ ´ç´¢º´ÀÌ ÀÖ´Â °æ¿ì¿¡ ¿©·¯ °¡Áö ÇÕº´ÁõÀÌ »ý±â´Âµ¥ À̰͵µ ´ç´¢º´ÀÇ Áß¿äÇÑ Áõ»óÀÌ µÈ´Ù. ´ç´¢º´ÀÇ ÇÕº´ÁõÀº ±Þ¼ºÀ¸·Î ´ë»çÀÇ ÀÌ»ó¿¡ ÀÇÇØ »ý±â´Â ¿©·¯ °¡Áö ÇÕº´Áõ°ú ¸¸¼ºÀûÀÎ Ç÷´çÀÇ »ó½ÂÀ¸·Î ÀÎÇØ ÀÛÀº Ç÷°üÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ »ý±â´Â ¸Á¸·, ÄáÆÏ, ½Å°æÀÇ ÀÌ»óÀÌ ÀÖ´Ù. ¢Â´ç´¢º´ÀÇ Áø´Ü ´ç´¢º´ÀÇ Áø´ÜÀº ºñÁ¤»óÀûÀ¸·Î Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ°¡ ³ôÀ» °æ¿ì¿¡ °¡´ÉÇØÁø´Ù. ºñÁ¤»óÀûÀ¸·Î ³ôÀº Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµÀÇ ±âÁØÀº 2ȸ ÀÌ»ó 10~16½Ã°£ °øº¹ÈÄ¿¡ Ç÷¾×¿¡¼ ÃøÁ¤ÇÑ ´çÀÇ ³óµµ°¡ 140mg/dlÀÌ»óÀ̰ųª, ½Ä»çÈÄ 2½Ã°£¿¡ ÃøÁ¤ÇÑ ´çÀÇ ³óµµ°¡ 200mg/dlÀÌ»óÀÎ °æ¿ì¿¡ Áø´ÜÀÌ µÈ´Ù. À̰ÍÀº Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ¸¦ ³·Ãß´Â Àν¶¸°ÀÇ ºÎÁ·À̳ª Àν¶¸°ÀÇ ±â´ÉÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ¼ Ç÷¾×¼ÓÀÇ ´çÀÌ ³ôÀº °ÍÀ» ÀǹÌÇÏ´Â °ÍÀÌ´Ù. ¢Â´ç´¢º´ÀÇ ºÐ·ù 1.Àν¶¸°ÀÇÁ¸´ç´¢º´: IDDM(Insulin-dependent diabetes mellitus)-IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁÖ·Î ¿øÀÎÀÌ ÃéÀå¿¡ ÀÖ´Â Àν¶¸°À» ºÐºñÇÏ´Â ¼¼Æ÷ÀÇ ÆÄ±«À̸ç ÀÌ·Î ÀÎÇØ¼ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²ÀÌ´Â Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇÏ´Â ¾à¹°ÀÌ ÀÌ IDDM¿¡¼´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀÎ Àν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù. 2.Àν¶¸° ºñÀÇÁ¸¼º ´ç´¢º´: NIDDM(Non-insulin-dependent Diabetes Mellitus)- NIDDMÀº Ä¡·á¿¡ Àν¶¸°ÀÌ ÇÊ¿äÇÏÁö ¾ÊÀº °æ¿ì¸¦ ¸»ÇÑ´Ù. À̰ÍÀº Àν¶¸°ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ »ý±â´Â °ÍÀÌ ¾Æ´Ï°í, ´ë½Å¿¡ °¢ ¼¼Æ÷µéÀÇ Àν¶¸°¿¡ ´ëÇÑ ¹ÝÀÀ¼ºÀÌ ¶³¾îÁ®¼ ´ç´¢º´ÀÌ »ý±â´Â °æ¿ì°¡ ´ëºÎºÐÀÌ´Ù. ±×·¯¹Ç·Î ÀÌÀÚ¿¡¼ Àν¶¸°ÀÇ ºÐºñ¸¦ Áõ°¡½ÃÄÑ ÁÖ´Â ¾à¹°¸¸À¸·Î Ä¡·á°¡ °¡´ÉÇϸç Àν¶¸°Àº ¾ÆÁÖ ½ÉÇÑ °æ¿ì¿¡ Á¦ÇÑÀûÀ¸·Î »ç¿ëÀÌ µÈ´Ù. Àν¶¸° ºñÀÇÁ¸Çü ´ç´¢º´Àº Áß³âÀ̳ª ³ëÀο¡°Ô¼ ÈçÈ÷ ¹ß°ßµÇ°í º¸Åë Áõ»óÀÌ ¶Ñ·ÇÇÏÁö ¾ÊÀº °æ¿ì°¡ ¸¹À¸³ª, ¾î¸°À̳ª û³âÃþ¿¡¼µµ ¹ß»ýÇϰí, Áõ»óÀÌ ²Ï ½ÉÇÒ ¶§µµ ÀÖ¾î¼ ´Ù¾çÇÑ ÆíÀÌ´Ù. °¡Á··ÂÀÌ °Çϰí ÀþÀºÀÌ¿¡¼ »ý±â´Â ÇüÀ» ¿¬¼ÒÇü Àν¶¸° ºñÀÇÁ¸Çü ´ç´¢º´À̶ó°í µû·Î ºÐ·ùÇÏ´Â ÇÐÀÚµµ ÀÖÀ¸³ª, ÀϹÝÀûÀ¸·Î ¹Þ¾Æµé¿©Áø ¿ë¾î´Â ¾Æ´Ï´Ù. °æÁ¦°³¹ßÀÌ ÁøÇàµÇ¸é¼, ºñ¸¸Áõµµ ÇÔ²² Áõ°¡Çϰí ÀÖÀ¸¸ç, ³²³àºñµµ ¿©¼ºÀÌ ´Ã¾î°¡´Â Ãß¼¼¸¦ º¸À̰í ÀÖ´Ù. ÀÌ ´ç´¢º´¿¡¼ÀÇ ¶Ç ´Ù¸¥ Ư¡Àº °ÇÑ °¡Á··ÂÀ̸ç, À̰ÍÀº À¯ÀüÀû ¿øÀÎÀ» °·ÂÈ÷ ½Ã»çÇÑ´Ù. ´ç´¢º´Àº Àν¶¸° ºÐºñÀÇ °áÇÌÀ̳ª ¶Ç´Â Àν¶¸°ÀÇ ¿µÇâÀ» ¹Þ´Â ¼¼Æ÷ÀÇ Àν¶¸°¿¡ ´ëÇÑ ¹ÝÀÀÀÇ ÀúÇÏ¿¡ ÀÇÇØ¼ °íÇ÷´çÀ» À¯¹ßÇÑ´Ù. °íÇ÷´ç ±× ÀÚü´Â ±×´ÙÁö ¹®Á¦°¡ µÇÁö ¾ÊÁö¸¸ Áö¼ÓÀûÀÎ °íÇ÷´çÀ¸·Î ÀÎÇØ¼ »ý±â´Â ¿©·¯ °¡Áö ÇÕº´ÁõÀÌ ´ç´¢º´È¯ÀÚ¿¡°Ô À־ Ç×»ó ¹®Á¦Á¡ÀÌ µÈ´Ù. ´ç´¢º´ÀÇ ÇÕº´Áõ¿¡´Â ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù. 1.±Þ¼º´ë»ç¼ºÇÕº´Áõ-´ç´¢º´¿¡¼ ºñ±³Àû ÈçÈ÷, ±×¸®°í ±Þ¼ºÀ¸·Î ¿Ã ¼ö ÀÖ´Â ÇÕº´ÁõÀ¸·Î ½ÉÇϸé ÀǽÄÀÇ Àå¾Ö, È¥¼ö¸¦ °¡Á®¿À´Â °ÍÀ¸·Î ÀúÇ÷´çÁõ, ÄÉÅæ»êÇ÷Áõ, °í»ïÅõ¾Ð¼º ºñÄÉÅæ¼º È¥¼ö°¡ ¿©±â¿¡ ¼ÓÇÑ´Ù. °¡)ÀúÇ÷´çÁõ(hypoglycemia)£Ä¡·á °úÁ¤¿¡¼ »ý±â´Â ÇÕº´ÁõÀ¸·Î ±Þ¼º´ë»ç¼º ÇÕº´Áõ Áß¿¡¼ °¡Àå ÈçÇÑ ÇüÅÂÀÌ´Ù. Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ°¡ ¶³¾îÁú °æ¿ì¸¦ ÀúÇ÷´çÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Ä¡·áÀÇ °úÀ׿¡ ÀÇÇØ¼ °úµµÇÑ Àν¶¸°ÀÇ ÀÛ¿ëÀ¸·Î Ç÷¾×¼ÓÀÇ ´çÀÌ °ÅÀÇ ´ëºÎºÐ ¼¼Æ÷¼ÓÀ¸·Î ÀúÀåÀÌ µÇ¾î¼ »ý±ä´Ù. Ç÷¾× ÁßÀÇ ´çÀÇ ³óµµ°¡ ÀÏÁ¤ ¼öÁØ ÀÌÇÏ·Î ¶³¾îÁú °æ¿ì¿¡´Â ¿À·ÎÁö ´ç¸¸À» ¿¡³ÊÁö¿øÀ¸·Î ÀÌ¿ëÇÏ´Â ³ú¿¡ °ø±ÞµÉ ´çÀÌ Àû¾îÁ®¼ ³ú±â´ÉÀÌ ÀúÇÏµÇ¸é¼ È¥¼ö »óÅ¿¡ µé¾î°¡°Ô µÈ´Ù. À̰ÍÀÇ Ä¡·á´Â ¿ì¼± ´ç´¢º´È¯ÀÚ¿¡°Ô Àû´çÇÑ Ä¡·á¸¦ ½ÃÇàÇÏ¿© Ç÷¾× Áß ´çÀÇ ³óµµ°¡ ÀÏÁ¤¼öÁØÀ» À¯ÁöÇÏ°Ô ÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇϸç, ¸¸¾à ÀúÇ÷´çÁõÀ¸·Î ÀÎÇÑ È¥¼ö°¡ ¿ÔÀ» °æ¿ì¿¡´Â Ç÷´çÀ» ³ôÀÌ´Â Á¶Ä¡(¿À·»Áö Á꽺, ÃÝÄÚ·¿ µîÀ» ¸ÔÀδÙ)¸¦ ÃëÇÏ´Â °ÍÀ¸·Î °£´ÜÈ÷ Ä¡·á°¡ µÉ ¼ö ÀÖ´Ù. ³ª)´ç´¢º´¼º ÄÉÅæ»êÇ÷Áõ(diabetic ketoacidosis)£ÄÉÅæÃ¼¶õ ´çÀÌ ¼¼Æ÷µéÀÇ ¿¡³ÊÁö¿øÀ¸·Î »ç¿ëµÉ ¼ö°¡ ¾ø´Â °æ¿ì(Á¤»óÀο¡°Ô¼´Â ÁÖ·Î Àå±â°£ ´Ü½ÄÀ» ÇÒ °æ¿ì¿¡ ¸¸µé¾îÁ® »ç¿ëÀÌ µÈ´Ù)¿¡ »ç¿ëÀÌ µÇ´Â ¿¡³ÊÁö¿øÀ¸·Î °£¿¡¼ »ý¼ºÀÌ µÈ´Ù. ´ç´¢º´¿¡¼µµ Àν¶¸°ÀÇ °áÇÌ¿¡ ÀÇÇØ¼ ¼¼Æ÷µéÀÌ ´çÀ» ¼·ÃëÇØ¼ ¿¡³ÊÁö¿øÀ¸·Î »ç¿ëÇÒ ¼ö°¡ ¾øÀ¸¹Ç·Î ÀÌ ÄÉÅæÃ¼¸¦ ¿¡³ÊÁö¿øÀ¸·Î ÀÌ¿ëÇÏ´Â °æ¿ì°¡ ÀÖ´Ù. ´ç´¢º´¼º ÄÉÅæ»êÇ÷ÁõÀ̶õ ÄÉÅæÃ¼°¡ ¿¡³ÊÁö¿øÀ¸·Î ¸ö¼Ó¿¡ ¸¹ÀÌ »ý±â´Â °ÍÀ» ¸»ÇÑ´Ù. ÄÉÅæÃ¼´Â »ê¼ºÀ» ¶ì´Â ¹°ÁúÀ̹ǷΠÀÌ ÄÉÅæÃ¼°¡ ¸ö¼Ó¿¡ ¸¹ÀÌ »ý¼ºÀÌ µÉ °æ¿ì¿¡´Â Ç÷¾×ÀÌ »ê¼ºÈµÇ°í ¶Ç ¸ö¿¡ ¾ÈÁÁÀº ÀÏ·ÃÀÇ °úÁ¤ÀÌ ÀϾÙ. ÁÖ·Î IDDMÀÇ °æ¿ì¿¡ ¸¹ÀÌ »ý±â¸ç, ½Ä¿å°¨Åð, ¿À½É, ±¸Åä, º¹Åë, ÀǽÄÀå¾Ö µîÀÇ Áõ»óÀÌ »ý±â¸ç ½ÉÇÏ¸é »ç¸Á¿¡ À̸£±âµµ ÇÑ´Ù. ´Ù)°í»ïÅõ¼º ºñÄÉÅæ¼º È¥¼ö(hyperosmolar nonketotic coma)£ÁÖ·Î NIDDMȯÀÚ¿¡°Ô¼ ÈçÇÑ À̰ÍÀº Áõ»óÀ̳ª ¹ß»ý±âÀüÀÌ ´ç´¢º´¼º ÄÉÅæ»êÇ÷Áõ°ú À¯»çÇÏÁö¸¸ ÄÉÅæÃ¼°¡ °ËÃâµÇÁö ¾Ê´Â´Ù´Â Ư¡ÀÌ ÀÖ´Ù. ÁÖ·Î °í·ÉÀÇ NIDDMȯÀÚ¿¡¼ ¸¹ÀÌ »ý±â¸ç ½ÉÇÑ Å»¼ö°¡ »ý±ä´Ù. Ç÷´çÀÌ ¾ÆÁÖ ³ô¾ÆÁö°í ȯÀÚÀÇ ÀǽÄÀÌ ¾ø´Â °æ¿ì°¡ ÈçÇÏ´Ù. 2.¸¸¼ºÇÕº´Áõ£´ç´¢º´ÀÇ »óŰ¡ Áö¼ÓµÇ¸é ¸¹Àº ȯÀÚ¿¡°Ô ÀÖ¾î¼ Ã¼³» ¿©·¯ Á¶Á÷ÀÇ º¯È°¡ ÀϾÙ. ÀÌ¿Í °°Àº º¯È´Â ´ë°³ Ç÷°üÀÇ º¯È¿¡ ±âÀÎÇÑ´Ù. ´ç´¢º´ÀÇ ¸¸¼ºÇÕº´ÁõÀº ¿øÀÎÀÎ Ç÷°üÀÇ º¯È¿¡ µû¶ó ´ëÇ÷°üÀÇ Àå¾Ö¿Í ¼ÒÇ÷°üÀÇ Àå¾Ö·Î ³ª´ ¼ö ÀÖ´Ù. °¡)´ëÇ÷°üÀÇ Àå¾Ö£Å« Ç÷°üÀÇ Àå¾Ö·Î ÀÎÇÑ ÇÕº´Áõ. ´ç´¢º´ÀÌ Áö¼ÓµÉ °æ¿ì¿¡´Â ´ëÇ÷°ü¿¡ µ¿¸Æ°æÈ°¡ Àß »ý±ä´Ù. ÀÌ·Î ÀÎÇØ¼ ³úÇ÷°üÁúȯÀ̳ª °ü»óµ¿¸ÆÁúȯÀÇ À§Ç輺ÀÌ Ä¿Áø´Ù. ³ª)¼ÒÇ÷°üÀÇ Àå¾Ö£ÀÛÀº ¼¼µ¿¸ÆÀÇ º´Àûº¯È·Î ÀÎÇØ¼ »ý±â´Â ¸¸¼ºÇÕº´Áõ. ¸Á¸·À̳ª ½ÅÀå, ½Å°æÀÇ ÀÛÀº µ¿¸Æ¿¡ ÀÌ»óÀÌ »ý±â¹Ç·Î ±×°÷¿¡µµ ÀÌ»óÀÌ »ý±ä´Ù. ´Ù)±âŸ-Ç÷´çÀÌ ³ô¾ÆÁú °æ¿ì¿¡´Â ¼¼±ÕÀÌ ¹ø½ÄÀ» ¸¹ÀÌ ÇÒ °¡´É¼ºÀÌ ³ô´Ù. Áï Ç÷¾×¼Ó¿¡ ¼¼±Õ¿¡°Ô ¿µ¾çÀ» Á¦°øÇÒ ¸¹Àº ´çÀÌ Á¸ÀçÇϹǷΠÁ¤»óÀκ¸´Ù ÈξÀ ´õ ¼¼±Õ°¨¿°ÀÇ È®·üÀÌ ³ô´Ù. ±×¸®°í ´ç´¢º´ÀÌ ÀÖÀ» °æ¿ì¿¡´Â ÇǺÎÀÇ Æ¯ÀÌÇÑ º´º¯ÀÌ »ý±â´Â °æ¿ì°¡ ÀÖ´Ù. ´ç´¢º´ÀÇ Ä¡·á´Â Ç÷¾×¼ÓÀÇ ´çÀÇ ³óµµ¸¦ Á¤»óÀ¸·Î À¯Áö½ÃŰ´Â °ÍÀÌ´Ù. Ç÷´çÀ» Á¤»óÀ¸·Î À¯ÁöÇϱâ À§ÇÑ ¹æ¹ýÀ¸·Î´Â ´ÙÀ½°ú °°Àº DEEDS¶ó´Â 5°¡ÁöÀÇ ¼ö´ÜÀÌ ÀÖ´Ù. DEEDS´Â ¿µ¾îÀÇ ¾ÕÀÚ¸¦ µû¼ ¸¸µç °ÍÀ¸·Î ¿ì¼± óÀ½ÀÇ D´Â Diet Áï ½Ä»çÀÇ Á¶ÀýÀ» ¸»ÇÏ´Â °ÍÀ¸·Î ½Ä»çÀÇ °úÀ×À» ¸·¾Æ¼ Ç÷´çÀ» Á¶ÀýÇÑ´Ù´Â °ÍÀÌ´Ù. Áï Ç÷´çÀÇ °ø±ÞÀ» Â÷´ÜÇÏ¿© Ç÷´çÀÌ °úµµÇÏ°Ô ³ô¾ÆÁö´Â °ÍÀ» ¸·´Â´Ù´Â ¶æÀ» °¡Áö°í ÀÖ´Ù. µÎ¹øÂ° ³ª¿À´Â E´Â EducationÀÇ ¾àÀÚÀÌ´Ù. Áï ȯÀÚÀÇ ±³À°À» ÅëÇØ¼ ȯÀÚÀÚ½ÅÀÌ Ç÷´çÀ» °ü¸®Çϵµ·Ï ÇÏ¿© ½º½º·Î »ì¾Æ°¥ ¼ö°¡ ÀÖ°Ô ÇÏ´Â °ÍÀÌ´Ù. ¼¼¹øÂ° E´Â ExerciseÀÇ ¾àÀÚ·Î ¿îµ¿À» ÅëÇØ¼ Ç÷´çÀ» ³·Ãßµµ·Ï ÇÏ´Â °ÍÀÌ´Ù. Áï ½Ä»ç Á÷ÈÄ¿¡ ÀÏÁ¤ÇÑ ¿îµ¿À» ÇÔÀ¸·Î½á ½Ä»ç·Î ÀÎÇØ¼ Ç÷´çÀÌ ¿Ã¶ó°¡´Â °ÍÀ» ¸·ÀÚ´Â °ÍÀÌ´Ù. ³×¹øÂ° ³ª¿À´Â D´Â DrugÀÇ ¾àÀÚ·Î ¾à¹°¿¡ ÀÇÇÑ Ä¡·áÀÌ´Ù. ¾à¹°¿¡´Â Àν¶¸°°ú °æ±¸Ç÷´ç°ÇÏÁ¦ÀÇ µÎ Á¾·ù·Î ³ª´«´Ù. Àν¶¸°Àº ´ç´¢º´ÀÚü°¡ Àν¶¸°ÀÇ ºÎÁ·À¸·Î »ý±â´Â º´À̹ǷΠÀν¶¸°À» ÁÖ»çÇÔÀ¸·Î½á ºÎÁ·ºÐÀÇ Àν¶¸°À» °ø±ÞÇÏ´Â °ÍÀÌ´Ù. °æ±¸Ç÷´ç°ÇÏÁ¦´Â ÃéÀåÀÇ ¼¼Æ÷¸¦ ÀÚ±ØÇÏ¿© Àν¶¸°ÀÇ ºÐºñ¸¦ Áõ°¡½ÃÄѼ ´ç´¢º´À» Ä¡·áÇÏ´Â ¾àÁ¦·Î Gilbenclamid, Chlorpropamide, Gliclazide µîÀÌ ÀÖ´Ù. ¸¶Áö¸·ÀÇ S´Â Self-MonitoringÀÇ ¾àÀÚ·Î ½º½º·Î ÀÚ½ÅÀÇ Ç÷´çÀ» üũÇÏ¿© ½Ä»ç, ¿îµ¿, ¾à¹°ÀÇ Á¶ÀýÀÌ ¾Ë¸ÂÀº Áö¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù. |
||
| ¿µ¹® | childhood diabetes | ÇÑ±Û | ¼Ò¾Æ´ç´¢º´ |
|---|---|---|---|
| ¼³¸í | ¼Ò¾Æ¿¡ ³ªÅ¸³ª´Â ´ç´¢º´. ´ç´¢º´Àº Àν¶¸° ºÎÁ·À¸·Î ü³» Æ÷µµ´ç ÀÌ¿ëÀÌ ÀúÇϵǾî ź¼öȹ°-Áö¹æ-´Ü¹éÁú ´ë»ç°¡ ÀåÇØ¸¦ ÀÏÀ¸Å°´Â Áúº´À¸·Î, ¼ºÀÎÇü ´ç´¢º´°ú ¿¬¼ÒÇü ´ç´¢º´ÀÌ ÀÖ´Ù. ¼ºÀÎÇüÀº Àν¶¸°ÀÇ »ó´ëÀû ºÎÁ·, Áï ºñ¸¸À¸·Î ÀÎÇÑ Àν¶¸° °¨¼ö¼ºÀÇ ÀúÇÏ °á°ú Àν¶¸° Çʿ䷮ÀÇ Áõ´ë¿¡¼ ¿À´Â °ÍÀ̸ç, ¼Ò¾ÆÇü ´ç´¢º´Àº ÀÌÀÚÀÇ ¶û°Ô¸£Çѽº¼¶ º£Å¸(¥â)¼¼Æ÷ÀÇ ÀåÇØ·Î ÀÎÇÑ Àν¶¸°ÀÇ Àý´ëÀû °áÇÌ¿¡¼ ¿Â´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ±ÇÀåÀ¸·Î 15¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â ´ç´¢º´À» ¸ðµÎ ¼Ò¾Æ´ç´¢º´À̶ó Çϴµ¥, ¾î¸°ÀÌ¿¡°Ôµµ °£È¤ ¼ºÀÎÇü(¶Ç´Â ºñ¸¸Çü) ´ç´¢º´ÀÌ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ´ç´¢º´À̶ó ÇÔÀº ¼Ò¾Æ±â¿¡ ¹ßº´ÇÏ´Â ¼Ò¾ÆÇü°ú ¼ºÀÎÇü ´ç´¢º´ÀÇ ÃÑĪÀ̶ó ÇÒ ¼ö ÀÖ´Ù. ÇöÀç±îÁö Åë°è¿¡ ÀÇÇϸé ÀüüÀα¸ÀÇ ¾à 5%´Â ´ç´¢º´À» °¡Áö°í ÀÖÀ¸¸ç, ±× °¡¿îµ¥ ¾à 2%°¡ 15¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù. |
||
| ¿µ¹® | diabetes insipidus | ÇÑ±Û | ¿äºØÁõ |
|---|---|---|---|
| ¼³¸í | 1ÀÏ ¼Òº¯ÀÇ ¾çÀÌ 4~15¸®ÅÍ·Î º´ÀûÀ¸·Î Áõ°¡ÇÏ´Â »óÅÂ. ÀÌ Áõ»óÀº ³úÀÇ ¹Ù´Ú¿¡ ºÙ¾î Àִ ȣ¸£¸óÀ» ÁÖ·Î ºÐºñÇÏ´Â ÀÛÀº ±â°üÀÎ ³úÇϼöü ÈÄ¿±¿¡¼ ºÐºñµÇ¾î ¼öºÐÀÇ Èí¼ö¸¦ ÃËÁøÇÏ¿© ü³»¿¡ ¼öºÐÀÇ ¾çÀ» ´ÃÀÌ´Â ¿ªÇÒÀ» ÇÏ°í µ¿½Ã¿¡ Ç÷°üÀ» ¼öÃà½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ¾î Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ¿ªÇÒµµ ÇÏ´Â ADH(Ç×ÀÌ´¢È£¸£¸ó)ÀÇ ºÎÁ·¿¡ ÀÇÇÑ´Ù. ADH°¡ ºÎÁ·µÉ °æ¿ì¿¡´Â ÄáÆÏ¿¡¼ ¼öºÐÀÇ Èí¼ö°¡ ÀϾÁö ¾Ê¾Æ¼ ¸¹Àº ¾çÀÇ ¼öºÐÀÌ ½ÅÀåÀ» ÅëÇØ °É·¯Á®¼ ¼Òº¯À¸·Î ³ª¿À°Ô µÈ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| PMD | Progressive Muscular Dystrophy; ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ Types of PMD(Progressive Muscular Dystroph... |
| DIDMOA | diabetes insipidus-diabetes mellitus-optic atrophy [syndrome] |
| DIMOAD | diabetes insipidus, diabetes mellitus, optic atrophy, deafness |
| TAPVR | Total Anomalous Pulmonary Venous Return = TAPVC 4 Types of TAPVR &... |
| T1DM | Type 1 diabetes mellitus |
|---|---|
| T2DM | Type 2 diabetes mellitus |
| DM | Diabetes Mellitus |
| DM2 | Diabetes Mellitus |
| IDDM | Diabetes mellitus |
| type I diabetes mellitus | <endocrinology> A severe metabolic disorder which has an abrupt onset before the age of twenty. In it, an insulin deficiency prevents the body from using carbohydrates properly and forces it to rely mainly on protein metabolism. Treatment of the disease includes strict dietary regulation and mandatory insulin injections. (09 Oct 1997) |
|---|---|
| non-insulin-dependent diabetes mellitus | <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop. (05 Mar 2000) |
| diabetes mellitus | <disease> Relative or absolute lack of insulin leading to uncontrolled carbohydrate metabolism. In juvenile onset diabetes (that may be an autoimmune response to pancreatic _ cells) the insulin deficiency tends to be almost total, whereas in adult onset diabetes there seems to be no immunological component but an association with obesity. (18 Nov 1997) |
| diabetes mellitus, experimental | Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by pancreatectomy. (12 Dec 1998) |
| diabetes mellitus, insulin-dependent | Diabetes mellitus characterised by insulin deficiency, sudden onset, severe hyperglycaemia, rapid progression to ketoacidosis, and death unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. (12 Dec 1998) |
| diabetes mellitus, lipoatrophic | A disorder characterised by complete absence of subcutaneous adipose tissue, insulin-resistant diabetes with little tendency to ketoacidosis, hyperlipidemia with subcutaneous xanthomatosis, hepatomegaly, and an elevated basal metabolic rate. (12 Dec 1998) |
| diabetes mellitus, non-insulin-dependent | Diabetes characterised by the ability to survive without ketoacidosis in the absence of insulin therapy. It is usually of slow onset and patients exhibit a tendency to obesity. (12 Dec 1998) |
| insulin-dependent diabetes mellitus | A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes. (09 Oct 1997) |
| diabetes, type 1 | Insulin dependent diabetes or juvenile diabetes. (12 Dec 1998) |
| diabetes, type 2 | Non-insulin dependent diabetes, adult-onset diabetes or insulin-resistant diabetes. (12 Dec 1998) |
| type 1 diabetes | <endocrinology> Also referred to as juvenile onset diabetes. Underlying cause is likely genetic. Usually treated with daily insulin dosing. Insulin is necessary for the body to properly utilise glucose. Without insulin, glucose accumulates in the bloodstream. (27 Sep 1997) |
| type 2 diabetes | <endocrinology> Also referred to as adult-onset diabetes. More common in the middle-age, overweight individual. Usually treated by diet control, weight reduction or oral hypoglycemic agents. (27 Sep 1997) |
| type I diabetes | A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes. (09 Oct 1997) |
| type II diabetes | <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop. (05 Mar 2000) |
| adult-onset diabetes | <disease> An often mild form of diabetes mellitus of gradual onset, usually in obese individuals over age 35; absolute plasma insulin levels are normal to high, but relatively low in relation to plasma glucose levels; ketoacidosis is rare, but hyperosmolar coma can occur; responds well to dietary regulation and/or oral hypoglycaemic agents, but diabetic complications and degenerative changes can develop. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|